[HIV-related thrombocytopenias]

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

[HIV-related thrombocytopenias]

Ann Ital Med Int. 2000 Jan-Mar;15(1):20-7. Unique Identifier : AIDSLINE MED/20301705
Mannucci PM; Gringeri A; Dipartimento di Medicina Interna, Centro Emofilia e Trombosi; Angelo Bianchi Bonomi, Universita degli Studi di Milano.; piermannuccio.mannucci@unimi.it

Abstract: Thrombocytopenia is a relatively frequent hematological complication in patients infected with the human immunodeficiency virus type 1. Occurring in all risk groups (homosexuals, intravenous drug addicts, hemophiliacs, heterosexuals) this complication has an overall prevalence varying between 5 and 15%. Only a relatively small proportion of patients have severe thrombocytopenia (6 to 24%), and life-endangering bleeding symptoms are not frequent. Accordingly, aggressive treatment is seldom indicated. Corticosteroids should be avoided because they may further compromise the deteriorated immune system of these patients. Splenectomy is efficacious as in patients with non-human immunodeficiency virus related immune thrombocytopenic purpura and infectious complications are not a prominent problem following the operation. Antiretroviral treatment with zidovudine and/or highly active protease inhibitors increases platelet count, but the control of thrombocytopenia is often transient when these drugs are stopped. Other treatments such as alpha-interferon and thrombopoietin require further experiences. On the whole, thrombocytopenia is generally a relatively mild complication of the human immunodeficiency virus infection and aggressive treatment is often unwarranted.

Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Anti-HIV Agents/THERAPEUTIC USE Drug Therapy, Combination English Abstract Human HIV Infections/BLOOD/*COMPLICATIONS/DRUG THERAPY *HIV-1/PATHOGENICITY Splenectomy Thrombocytopenia/BLOOD/EPIDEMIOLOGY/*ETIOLOGY/THERAPY
001030
A00A1141

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .